Related Experiment Video

Updated: Aug 29, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

In vitro antibacterial activity of the peptide PsVP-10 against antimicrobial-resistant Enterococcus faecalis isolated

C Padilla1, O Lobos, P Brevis

  • 1Laboratorio de Investigación Microbiológica and Instituto de Biología Vegetal y Biotecnología, Universidad de Talca, Talca, Chile. cpadilla@utalca.cl

The Journal of Antimicrobial Chemotherapy
|January 20, 2004
PubMed
Abstract

Insights

The peptide PsVP-10 shows promising antimicrobial activity against multidrug-resistant Enterococcus faecalis. This research highlights its potential as a novel therapeutic agent against challenging bacterial infections.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Enterococcus faecalis is a significant cause of hospital-acquired infections.
  • Increasing antimicrobial resistance in E. faecalis necessitates novel therapeutic strategies.
  • Multidrug-resistant phenotypes of E. faecalis exhibit high resistance to conventional antibiotics.

Purpose of the Study:

  • To evaluate the antimicrobial efficacy of the peptide PsVP-10.
  • To assess PsVP-10 activity against clinical isolates of resistant Enterococcus faecalis.

Main Methods:

  • Disc diffusion assay for qualitative antimicrobial activity.
  • Determination of Minimum Inhibitory Concentrations (MICs).
  • Testing against 67 multidrug-resistant and susceptible E. faecalis strains.

Main Results:

  • Demonstrated multidrug-resistant phenotypes of E. faecalis with high MICs to common antibiotics.
  • Peptide PsVP-10 exhibited lower MICs compared to conventional antibiotics.
  • PsVP-10 showed consistent antimicrobial activity against both resistant and susceptible strains.

Conclusions:

  • There is an urgent need for new antimicrobial agents to combat resistant E. faecalis.
  • The peptide PsVP-10 demonstrates potential as a novel antimicrobial agent.
  • PsVP-10 may contribute to addressing the challenge of multidrug-resistant E. faecalis infections.

More Related Videos

Production and Testing of Antimicrobial Peptides and Their Mimics10:35

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...